This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Explore a curated set of 5 Hedge Funds articles, from Tepper's AI bets to Ackman's AI moves, showing how big bets can influence risk, diversification, and portfolio growth.
129 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Hedge-fund CIOs say the refining space offers persistent profit potential due to structural capacity limits, even as ...
One of Wall Street’s hottest hedge funds is riding a two-trade surge, concentrated in Nvidia and Meta Platforms, as i...
A wave of new positions from hedge funds loading boeing points to a cautious but growing bet that Boeing can rebound ...
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Prentice Capital has exited its Compass position, reporting a zero stake after the latest quarter. This move highligh...
A billionaire hedge fund manager shows the power of high-conviction bets in AI. This article breaks down Ackman'...
A big-name hedge fund recently disclosed a fresh stake in a leading utility company, adding roughly 1.9 million share...
A major hedge fund trimmed its ZoomInfo position by millions, fueling questions about the company's prospects. This a...
Discover how Marek Capital's co-founder approaches credit, risk, and portfolio design. This practical, investor-focus...
Hightower’s active bets in Netflix, Target, and Broadcom surface as Nvidia prepares to unveil new AI developments at ...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...